|
The foundation, represented by Executive Director Harriet Patterson, MPH, was among 20 groups featured in an Advocates Poster Session during the AACR conference. The poster highlighted our impact in accelerating research and supporting patients, including creating the Gastric Cancer Registry at Stanford University, funding seed grants and offering an online clinical trial finder and patient-support community. Board member Hans Rueffert, our patient advocate and “chef without a stomach,” also represented the foundation at the conference hosting GCF’s booth in the Patient Advocacy Pavillion where he connected with researchers, clinicians, pharma companies, other patient advocates and more.
The Gastric Cancer Registry was featured prominently at the AACR conference, with two studies co-authored by Stanford professor and the registry’s primary investigator, Hanlee Ji, MD. In one study, a Stanford University team used registry data to identify three genes that may raise the risk of stomach lesions progressing to gastric cancer. In the second study, researchers analyzed sequencing data, as well as spacial transcriptomics and proteomics data from more than 200 stomach tumor samples that are housed in public and in-house resources, including the registry.
Foundation board member Ajay Goel, PhD, of City of Hope, was also featured prominently at the AACR conference, co-chairing a symposium on advances in liquid biopsy technology. “Liquid biopsy technology could be revolutionary not just for predicting cancer before symptoms appear, but also for improving how patients are treated after diagnosis and for preventing recurrence,” Dr. Goel said after the symposium. “There is a lot of exciting research now looking at monitoring immune cells and other types of cells along with liquid biopsies, which could help oncologists adjust treatments based on the likelihood of recurrence. It’s very exciting—these diagnostics could play a big part in improving precision approaches in gastric cancer.”
All in all, the AACR conference marked a valuable opportunity to not only highlight the work of the Gastric Cancer Foundation, but also to connect with our partners and learn about exciting emerging science that promises to improve the lives of the patients we serve.
|